← Open Payments lookup

SAMANTHA TOLLEY-MUSALL: Open Payments

NPI 1184261166 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,229 in 72 payments from 15 companies in 2025. Trend: 2023 $26 · 2024 $726 · 2025 $1,229

Food & beverage: $1,229
CompanyPaymentsAmount
ABBVIE INC.21$216
Corium, LLC16$178
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$178
Otsuka America Pharmaceutical, Inc.8$162
Axsome Therapeutics, Inc.5$143
Supernus Pharmaceuticals, Inc.1$125
Takeda Pharmaceuticals U.S.A., Inc.3$53
Noven Therapeutics, LLC2$44
Vanda Pharmaceuticals Inc.1$36
Janssen Pharmaceuticals, Inc1$20

Products named: VRAYLAR, Azstarys, CAPLYTA, Auvelity, Qelbree, REXULTI, TRINTELLIX, Xelstrym.

Industry payments across IN — which companies pay providers there.